Skip to content
Biopterre logo — Centre de développement des bioproduits
Innovateur de nature

Biopterre

Centre de développement des bioproduits Innovateur de nature

Founded 2007 Canada La Pocatiere, Canada 48 employees Biotechnology, ESG +1

General Information

Company Name Biopterre
Founded Year 2007
Location Canada La Pocatiere, Canada
Employees 48
Industries Biotechnology, ESG, Education
Social

BounceWatch is an independent company data service, not affiliated with Biopterre. To contact Biopterre, visit biopterre.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biopterre compare?

A PDF of Biopterre and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biopterre soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biopterre

Biopterre has established itself since its founding in 2007 as a pivotal player in the intersection of Biotechnology, ESG, and Education. With its headquarters in Canada, the company is driven by its motto, "Centre de développement des bioproduits Innovateur de nature." This reflects their commitment to innovating sustainably and supporting enterprises through applied research, technological development, and comprehensive education programs.

Their expertise spans product development and process enhancement, offering essential services like technology validation, adaptation, and knowledge transfer. Additionally, Biopterre empowers organizations through bespoke training, feasibility studies, and the organization of educational events. They have yet to disclose any specific investment rounds or funding from notable investors. The company's unique amalgamation of hands-on innovation and educational outreach makes it a compelling opportunity for investors seeking to explore sustainable and technologically advanced ventures.

Business keywords: Bioproduits, Innovation, Recherche appliquée, Développement technologique, Soutien technique, Formation, Biotechnologies, Produits horticoles, Biomasse, Technologies environnementales, Mycotechnologies, PFNL, Cultures innovantes

No funding data available for Biopterre yet.

Biopterre Alternatives & Competitors

View All Alternatives
Biopterre vs
Algenesis Labs
Algenesis Labs United States

Algenesis is a material science and technology company on a mission to help the planet recover from...

Venture round
21 employees
Biotechnology, ESG
Biopterre vs

Wir schaffen Wissen – heute für morgen

1662 employees
Biotechnology, Education
Biopterre vs
4D LABS
4D LABS Canada

Innovative R&D solutions for academic and industry pioneers.

Grant
11 employees
Biotechnology, Education

FAQ About Biopterre

Centre de développement des bioproduits Innovateur de nature
Biopterre was founded in 2007.
Biopterre is headquartered in La Pocatiere, Canada.
Biopterre operates in Biotechnology, ESG and Education. Its work centres on Bioproduits, Innovation, Recherche appliquée and Développement technologique.
Biopterre has approximately 48 employees.
Top alternatives and competitors to Biopterre include Algenesis Labs, PSI Paul Scherrer Institut, 4D LABS, LIME TECHNOLOGY IKE, GyroTools LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biopterre and Algenesis Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biopterre, https://bouncewatch.com/company/biopterre, updated 28 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout